Labcorp stock trades close to 52-week high as earnings momentum supports gains
Published on 08/22/2026 at 13:06 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Labcorp Holdings Inc. (US50540R4092) stock is quoted at $333.67 as of August 21, 2026, keeping the shares close to their recent 52-week high range and extending a year-to-date gain of 31.78 percent according to a detailed CBOE-based quote snapshot as reported in a recent quote overview.
Stock holds strong after recent gains
The same August 21, 2026 quote data shows Labcorp trading at $333.67, up 0.25 percent intraday after a prior close at $332.83, underlining that the stock continues to edge higher even after a strong run since the start of 2026 based on the cited CBOE-linked snapshot.
From a starting level of $250.87 on January 1, 2026, Labcorp shares have advanced to the low-$330s range by late August, corresponding to a gain of more than 30 percent over this period as shown in a recent performance overview.
Earnings growth and valuation context
Recent analysis highlighting Labcorp points to expected earnings per share rising from $18.32 to $19.66 over the coming year, an anticipated increase of 7.31 percent that underscores ongoing profit growth plans for the company based on a detailed earnings expectations summary.
The same overview cites a current price-to-earnings ratio of 27.52 for Labcorp, set against a broader market average P/E of 39.51, suggesting that the shares trade at a discount to the wider market on this metric while still reflecting solid growth expectations using the published valuation comparison.
Historically, Labcorp has also delivered revenue growth, with one recent quarterly report indicating revenue up 5.8 percent compared with the same quarter of the prior year and earnings per share of $4.99 beating consensus estimates by $0.21, though this earlier period serves primarily as a reference point for the companys trajectory according to a summarized quarterly results recap.
Diagnostics and lab services underpin the business
Labcorp generates its revenue by operating a broad network of diagnostic laboratories and related services that support physicians, hospitals, and biopharmaceutical customers in areas such as routine blood testing, specialized diagnostics, and central lab services for clinical trials.
These activities position the company to benefit from growing demand for testing and data-driven healthcare, while also providing a recurring revenue base that can help smooth results over different economic cycles.
Labcorp stock and current market level
As of August 21, 2026, 10:33 a.m. ET, Labcorp stock trades at $333.67 on a US exchange, representing a 0.25 percent gain on the session and a 31.78 percent advance since January 1, 2026, which leaves the shares trading close to their 52-week high range and reflects solid investor confidence in the companys earnings outlook.
Fact box
Company: Labcorp Holdings Inc.
ISIN: US50540R4092
Ticker: LH
Exchange: NYSE
Price (as of August 21, 2026, 10:33 a.m. ET): $333.67 USD
Sector / Industry: Healthcare / Diagnostics and research
